Results 151 to 160 of about 3,197,524 (305)

Effects of Intensive Systolic Blood Pressure Control on Kidney Outcomes in Patients With and Without CKD: A Post Hoc Analysis of SPRINT and ACCORD‐BP Trials

Journal of Diabetes
Background The effects of intensive blood pressure (BP) control on adverse kidney outcomes remain undetermined. Methods This post hoc analysis included the Systolic Blood Pressure Intervention Trial (SPRINT) participants and the Action to Control ...
Xiaoli Xu, Xuan Zhao, Yi Ding, Xianglin Wu, Qiuyu Cao, Kan Wang, Yu Xiang, Siyu Wang, Xiaoyun Zhang, Min Xu, Tiange Wang, Zhiyun Zhao, Yuhong Chen, Jieli Lu, Yufang Bi, Mian Li, Yu Xu   +16 more
doaj   +1 more source

Chorea: An unusual manifestation of endocrine diseases. [PDF]

Front Endocrinol (Lausanne), 2023
Zheng J, Wu X.
europepmc   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Correction to: BMP9 reduces age-related bone loss in mice by inhibiting osteoblast senescence through Smad1-Stat1-P21 axis

Cell Death Discovery, 2022
Jing-zun Xu, Yan-man Zhou, Lin-lin Zhang, Xiao-jing Chen, Yu-ying Yang, Deng Zhang, Ke-cheng Zhu, Xiao-ke Kong, Li-hao Sun, Bei Tao, Hong-yan Zhao, Jian-min Liu   +11 more
doaj   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks, Mujeeb Shittu, Anna Wolska, Diala Ghazal, Bianca Weinstock‐Guttman, Alexander Burnham, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +8 more
wiley   +1 more source

Engineered Dynamic Hydrogel Niches for the Regulation of Redox Homeostasis in Osteoporosis and Degenerative Endocrine Diseases. [PDF]

Gels, 2023
Yuan W, Xu J, Yang N, Wang H, Li J, Zhang M, Zhu M.   +6 more
europepmc   +1 more source

Endocrine Disease and Apoptosis.

Internal Medicine, 1998
openaire   +4 more sources

Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Given the role of Myostatin (MSTN) in muscle homeostasis and its modulation by current spinal muscular atrophy (SMA) therapies, we investigated serum MSTN and, for the first time, its downstream effector Smad3 as candidate non‐invasive biomarkers in SMA patients undergoing disease‐modifying therapies (DMTs).
Giorgia Riolo, Claudia Dosi, Stefano Parravicini, Riccardo Zanin, Marta Cheli, Eleonora Giacopuzzi Grigoli, Amalia Canciello, Francesca Andreetta, Riccardo Masson, Silvia Bonanno, Stefania Marcuzzo, Lorenzo Maggi   +11 more
wiley   +1 more source

Gut microbiome and reproductive endocrine diseases: a Mendelian randomization study. [PDF]

Front Endocrinol (Lausanne), 2023
Liang Y, Zeng W, Hou T, Yang H, Wu B, Pan R, Huang L.   +6 more
europepmc   +1 more source